Markers of T-cell senescence and physical frailty: insights from Singapore Longitudinal Ageing Studies

T细胞衰老和身体虚弱的标志物:来自新加坡纵向老龄化研究的启示

阅读:1

Abstract

BACKGROUND: Elderly individuals have an eroded immune system but whether immune senescence is implicated with the development of frailty is unknown. The underlying immune mechanisms and the link between markers of senescence and physical frailty is not well established. METHODS: We explored the association of specific T-cell subset markers of immune differentiation and senescence on CD4(+) and CD8(+) cells (CD28(-), CD27(-) and CD57(+)) and the immune risk profile (inverted CD4/CD8 ratio <1) with physical frailty among 421 participants who were frail (N=32), prefrail (N=187) and robust (N=202) in the Singapore Longitudinal Ageing Study cohort. RESULTS: In ordinal logistic regression models relating tertile category rank scores of immune biomarker with frailty status (robust, prefrail and frail), CD8(+)CD28(-)CD27(+) (odds ratio (OR)=1.35, P=0.013), CD4(+)CD28(-)CD27(+) (OR=1.29, P=0.025), CD8(+)CD28(-) (OR=1.31, P=0.022), and CD4/CD8 ratio (OR=1.27, P=0.026) were positively associated with frailty, controlling for age, sex and multimorbidity. CD4/CD8 ratio less than one was not associated with frailty (OR=0.84, P=0.64). In stepwise multinomial logistic regression controlling for age, sex and comorbidity, only CD8(+)CD28(-)CD27(+) was the independent predictor of prefrailty: highest tertile of the immune marker significantly predicted prefrailty (versus low tertile, OR=1.72, P=0.037) and frailty (OR=2.56, P=0.06). CONCLUSION: The study supports the hypothetical role of immune senescence in physical frailty, particularly in regard to the observed loss of CD28 expression from both CD8(+) cells and CD4(+) cells, but not for CD27 or CD4/CD8 ratio as a marker of senescence. The potential of CD8(+)CD28(-)CD27(+) as a biological marker of frailty should be further investigated in prospective studies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。